Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)

Clinical trial NCT02130999 · COMPLETED

Trial details

NCT number: NCT02130999
Sponsor: Vanda Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-24-Hour-Sleep-Wake Disorder

Start date: 2014-05-01
Primary completion: 2014-05-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.